The Veterinary Services industry has performed well over the past few years. A surge in pet ownership in response to the COVID-19 pandemic, growing awareness of animal health and the increasing availability of advanced surgical and diagnostic procedures for animals have benefited veterinarians. Pet owners are becoming increasingly willing to spend more on pets and vet procedures to prolong their lives. This trend is also partly in response to a rising number of high-income earners across the economy. Revenue surged over the two years through 2021-22, as more households purchased companion animals in response to COVID-19 lockdowns. In recent years, this strong demand growth for veterinary services has slowed as cost-of-living pressures and slumps in discretionary incomes have prompted pet owners to delay some services. Many veterinarians are providing more complex services to pet owners, increasing their revenue per visit. Yet, veterinarian practices have grappled with staffing shortages, meaning that, in many cases, demand is outstripping supply, hampering revenue growth. Overall, revenue for veterinary services providers is expected to have climbed at an annualised 4.0% over the five years through 2024-25, to $5.7 billion. This trend includes an anticipated rise of 1.0% in 2024-25 as pet numbers grow and more households require veterinary procedures for their pets. With solid revenue growth and strong demand, profitability is also climbing. Developments in the veterinary sector, including new medical treatments for pets, benefit vets. Deregulation is also fuelling brand name expansions, which VetPartners’ and Apiam's rapid growth, along with heightening industry concentration, are demonstrating. As industry ownership was previously limited to veterinarians, deregulation is allowing participants to raise equity from a broader market to fund expansion activities. Strengthening discretionary incomes and higher veterinary practitioner numbers are set to fuel a positive performance in the coming years. Vets will promote a greater range of value-added services and hike prices to bolster revenue growth. Veterinary services’ revenue is forecast to expand at an annualised 2.8% over the five years through 2029-30, to reach $6.6 billion.

The Australia Veterinary Industry market report segments the industry into By Product (Therapeutics, Diagnostics) and By Animal Type (Dogs and Cats, Horses, Ruminants, Swine, Poultry, Other Animal Types). Get five years of historical data alongside five-year market forecasts.

Number of Businesses statistics on the Veterinary Services industry in Australia

The Australia Pet Food Market report segments the industry into Pet Food Product (Food, Pet Nutraceuticals/Supplements, Pet Treats, Pet Veterinary Diets), Pets (Cats, Dogs, Other Pets), and Distribution Channel (Convenience Stores, Online Channel, Specialty Stores, Supermarkets/Hypermarkets, Other Channels). Get five years of historical data alongside five-year market forecasts.

The veterinary medicine vaccines market in Australia and Oceania stood at $348M in 2024, remaining relatively unchanged against the previous year. The total consumption indicated strong growth from 2012 to 2024: its value increased at an average annual rate of +5.8% over the last twelve-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2024 figures, consumption decreased by -0.9% against 2021 indices.

Veterinary pharmaceutical manufacturers have endured their fair share of challenging trading conditions. Demand from downstream beef, cattle and sheep farming has been volatile thanks to seasonal weather patterns that battered farmers with either prolonged drought conditions or flooding. Stringent regulatory controls, higher compliance costs and growing consolidation pressures have compounded this issue, prompting several major global pharmaceutical companies to divest their veterinary pharmaceutical operations. Yet it hasn't all been bad news for manufacturers, with a surge in pet ownership amid COVID-19 lockdowns fuelling demand for products for companion animals. Shifting trends towards pet humanisation, where companion animals are treated as part of the family, and consumers’ willingness to spend more on pet health and wellbeing have supported sales. The pandemic also drove a heightened focus on protecting both human and animal populations, spurring the development of innovative vaccines and greater use of preventative care products to reduce pathogen contamination risks. All-in-all, revenue is anticipated to have grown at an annualised 2.0% over the past five years and is expected to total $1.3 billion in 2024-25, when it will grow by an estimated 3.9%. Going forwards, industry revenue is forecast to rise at an annualised 2.9% over the five years through 2029-30 to total $1.5 billion. The rising prevalence of animal and zoonotic diseases will drive the development of new animal health vaccines and products, as will new technologies like biologics. Ongoing product innovations and advanced technology that help livestock farmers monitor animal health issues will become a potential growth area for manufacturers. In light of the recent boom in pet ownership during the pandemic, rising household discretionary incomes, higher veterinarian numbers and a desire for quality pet care are set to fuel higher spending on veterinary pharmaceuticals. However, ongoing regulatory compliance will limit profitability.

The industry’s operating backdrop has changed dramatically over the past few decades. Changing policy landscapes have seen state governments wind back their involvement in the industry, creating space for a variety of participants, including the local operations of US-based IDEXX Laboratories and ASX-listed pathology provider Australian Clinical Labs. Technological advancements and the consequences of ongoing globalisation and the rapid global spread of animal and zoonotic diseases have also transformed the industry’s operating environment. The COVID-19 pandemic has highlighted both the threat of global zoonotic diseases and the integral role that the industry plays in protecting Australia's animal health system. In April 2020, CSIRO's high-containment biosecurity facility, the Australian Animal Health Laboratory, was renamed the Australian Centre for Disease Preparedness (ACDP) to reflect the changing nature of emerging infectious diseases that affect both human and animal health. Continued demand for the industry's services has contributed to modest growth in revenue and profit. Industry revenue is expected to have grown at an annualised 2.3% over the five years through 2024-25, to $370.0 million. This trend includes an anticipated expansion of 1.5% in 2024-25, as focus heightens on animal health and biosecurity and the threat of emergency animal disease incursions, like high pathogenicity avian influenza. Revenue is forecast to grow at an annualised 2.0% over the five years through 2029-30, to $408.5 million. Increased demand from veterinary practitioners and consumers’ willingness to spend more on their pets' general health and wellbeing will benefit the industry. Additional government measures to improve Australia's biosecurity system and the adoption of a One Health model will stimulate further changes in the industry's operating landscape, as will a growing focus on zoonotic diseases in the wake of the global COVID-19 pandemic. The use of innovative technologies in the wider animal care sector will also influence the industry going forwards.

The UK Veterinary Healthcare Market Report is Segmented by Product (Therapeutics, Diagnostics, and Other Products) and Animal Type (Dogs and Cats, Horses, Ruminants, Swine, Poultry, and Other Animal Types). The Report Offers the Value (USD) for the Above Segments.

The veterinary vaccine market in Australia is expected to see steady growth over the next decade, driven by increasing demand. Market performance is forecast to expand with a slight increase in both volume and value terms by the end of 2035.

Employment statistics on the Veterinary Services industry in Australia

Discover insights into the veterinary medicine vaccine market in Australia, including projected growth in both volume and value over the next decade.

Australia Industry Value Added: Manufacturing: PM: Veterinary data was reported at 345.000 AUD mn in 2023. This records a decrease from the previous number of 369.000 AUD mn for 2022. Australia Industry Value Added: Manufacturing: PM: Veterinary data is updated yearly, averaging 179.000 AUD mn from Jun 2007 (Median) to 2023, with 17 observations. The data reached an all-time high of 369.000 AUD mn in 2022 and a record low of 118.000 AUD mn in 2007. Australia Industry Value Added: Manufacturing: PM: Veterinary data remains active status in CEIC and is reported by Australian Bureau of Statistics. The data is categorized under Global Database’s Australia – Table AU.RT001: Industry Value Added: by ANZSIC Class.

Comprehensive dataset of 489 Veterinary cares in Australia as of June, 2025. Includes verified contact information (email, phone), geocoded addresses, customer ratings, reviews, business categories, and operational details. Perfect for market research, lead generation, competitive analysis, and business intelligence. Download a complimentary sample to evaluate data quality and completeness.

Comprehensive dataset of 164 Veterinary pharmacies in Australia as of July, 2025. Includes verified contact information (email, phone), geocoded addresses, customer ratings, reviews, business categories, and operational details. Perfect for market research, lead generation, competitive analysis, and business intelligence. Download a complimentary sample to evaluate data quality and completeness.

Owning a pet in Australia is relatively common. In a survey conducted in 2016 about pet ownership in the country, the age bracket with the highest rate of pet ownership was ** to 24-year-olds, with around ** percent of survey respondents in that age range claiming to have a pet in their household. Pet ownership tended to decline for respondents from older age brackets; in fact, less than ** percent of people 65 years and older owned a pet. Pets included dogs, cats, fish, birds, reptiles and small mammals.

What is the pet situation?

In 2015, the most common pet owned by Australians were dogs; almost ** percent of pet owners had at least one in their household. Dogs in Australia are not only companion animals but can also take on pet therapy, assistance and working roles. Although Australia has one of the highest pet ownership rates in the world, the leading reason for not owning a pet or getting another pet was that respondents’ lifestyles or homes were not suitable.

Pet care and expenditure

Food and veterinary services contributed the most to expenses for people owning pets in Australia. The pet food market is a billion-dollar industry in Australia alone. As Australians become more conscious of ingredients in products, the quality may increase as consumers expect more or are willing to pay more for pet food. In fact, premium and super-premium pet food products accounted for the majority share of sales in the country in 2017. The market is expected to grow annually into the foreseeable future, with product innovation directed by consumer trends.

Statistics illustrates market overview of vaccines for veterinary medicine in Australia from 2007 to 2024.

The Australian pet food market, valued at approximately $XX million in 2025, exhibits robust growth potential, projected to expand at a compound annual growth rate (CAGR) of 4.30% from 2025 to 2033. This growth is fueled by several key drivers. Firstly, increasing pet ownership, particularly of dogs and cats, forms a strong foundation for market expansion. Secondly, a rising trend towards premiumization is evident, with pet owners increasingly prioritizing high-quality, nutritious, and specialized pet foods. This is reflected in the popularity of pet nutraceuticals and veterinary diets catering to specific health needs. The growing humanization of pets further contributes to this trend, leading to increased spending on pet food and related products. Finally, the burgeoning online channel offers convenient access to a wider range of products, driving sales growth. While the market faces potential restraints such as economic fluctuations impacting consumer spending, the overall positive growth trajectory suggests a strong future for the Australian pet food industry. Despite potential challenges, market segmentation presents diverse opportunities. The dry pet food segment, particularly kibbles, remains dominant, however, wet pet food and pet treats (especially premium and specialized options) are experiencing significant growth. The pet nutraceuticals segment also shows promising potential, reflecting owners' increasing focus on pet health and well-being. Distribution channels are diversifying, with online channels gaining prominence alongside traditional avenues like supermarkets and specialty stores. Key players like Mars Incorporated, Nestle (Purina), and others are leveraging these trends through product innovation, brand building, and strategic distribution partnerships to capture market share. The continued expansion of the pet ownership base coupled with increasing consumer awareness regarding pet nutrition will be crucial catalysts in shaping the market's future growth. This comprehensive report provides an in-depth analysis of the Australia pet food market, covering the period from 2019 to 2033. It offers invaluable insights into market size, segmentation, trends, and future growth projections, equipping businesses with the knowledge to navigate this dynamic sector. The report leverages data from the historical period (2019-2024), base year (2025), and estimated year (2025), projecting growth until 2033. Keywords: Australia pet food market, Australian pet food industry, pet food market size Australia, pet food trends Australia, dog food market Australia, cat food market Australia, pet treats market Australia, pet supplements Australia, pet nutrition Australia, pet food sales Australia. Recent developments include: July 2023: Hill's Pet Nutrition introduced its new MSC (Marine Stewardship Council) certified pollock and insect protein products for pets with sensitive stomachs and skin lines. They contain vitamins, omega-3 fatty acids, and antioxidants.May 2023: Nestle Purina launched new cat treats under the Friskies "Friskies Playfuls - treats" brand. These treats are round in shape and are available in chicken and liver and salmon and shrimp flavors for adult cats.April 2023: Mars Incorporated opened its first pet food research and development center in Asia-Pacific. This new facility, called the APAC pet center, will support the company's product development.. Key drivers for this market are: Increased Demand for Meat, Initiatives By the Key Players; Focus on Animal nutrition and Health. Potential restraints include: Shift Toward Vegan- Based Diet, Changing Raw Material Prices and Strict Government Rules to Restrict Market Growth. Notable trends are: OTHER KEY INDUSTRY TRENDS COVERED IN THE REPORT.

The global animal health industry is projected to reach a market size of USD XX million by 2033, exhibiting a CAGR of 9.75% during the forecast period 2025-2033. Key drivers of this growth include the rising demand for companion and food-producing animals, the increasing prevalence of animal diseases, and growing awareness of animal health and welfare. The industry is also witnessing advancements in diagnostics and therapeutics, along with the adoption of digital technologies. The market is segmented based on product type (therapeutics and diagnostics), animal type (companion animals, livestock, and others), and region (North America, Europe, Asia Pacific, South America, and Middle East & Africa). The therapeutics segment holds a significant share due to the widespread use of vaccines, parasiticides, anti-infectives, and other treatments. The companion animal segment is the largest animal type due to the growing popularity of pet ownership. Regionally, North America and Europe currently dominate the market, but Asia Pacific is expected to witness substantial growth in the coming years. Leading companies in the industry include Chemvet Australia Pty Ltd, Elanco, Merck Co Inc, QBiotics Group Limited, and Zoetis Inc. Recent developments include: In August 2021, Zoetis Inc. entered an agreement to buy Jurox, a privately held Australian animal health firm that develops, manufactures, and markets veterinary pharmaceuticals for companion animals and livestock. This provides future growth potential, manufacturing capacity, and expanded skills in the Australian animal health market., In March 2021, Arrotex Pharmaceuticals and Zoetis, a pharmaceutical business, have teamed up to market the pet-care brand's Revolution and Simparica, which will be sold by Sigma Wholesale.. Key drivers for this market are: Increase In Animal Adoption Coupled with Increasing Awareness about Animal Healthcare, Advanced Technology in Animal Healthcare. Potential restraints include: Use of Counterfeit Medicines, Increasing Costs of Animal Testing and Veterinary Care. Notable trends are: Vaccines Segment Holds a Major Share in the Market.

Australia Pet Food Market size was valued at USD 2.75 Billion in 2024 and is projected to reach USD 4.10 Billion by 2031, growing at a CAGR of 5.2% from 2024 to 2031.

Australia Pet Food Market Drivers

Increase in Pet Ownership: Australia’s pet ownership has increased by 15% from 2019 to 2023. According to the Australian Bureau of Statistics, around 61% of households will own pets by 2023, increasing demand for high-quality pet food across the country.

Shift toward Premium Pet Foods: Australian pet owners prefer expensive, health-focused meals. In August 2023, Euromonitor reported that premium pet food sales in Australia increased by 9% year on year, with a focus on organic, grain-free, and protein-rich alternatives.

Government Support for the Pet Care Industry: The Australian government has backed the pet care industry with programs such as the “National Pet Strategy,” which was released in May 2023. This effort intends to boost the pet care and related businesses, including pet food, by creating a favorable environment for market growth.

Expanding Online Retail Channels: The rise of e-commerce has had a huge impact on pet food sales in Australia. In February 2024, Petbarn, one of Australia’s biggest pet stores, announced a 25% growth in online pet food sales, showing the growing consumer preference for easy online purchasing platforms.

The global veterinary infectious disease diagnostics market is estimated to reach a valuation of US$ 1.9 billion in 2023. As per Future Market Insights (FMI) analysis, the veterinary infectious disease diagnostics market size is expected to surpass US$ 4.9 billion in the next decade. Between 2023 and 2033, the market has been forecast to register a 10.1% CAGR.

Attributes	Details
Veterinary Infectious Disease Diagnostics Market CAGR (2017 to 2022)	11.9%
Veterinary Infectious Disease Diagnostics Market CAGR (2023 to 2033)	10.1%
Market Size for Veterinary Infectious Disease Diagnostics (2023)	US$ 1.9 billion
Market Size forVeterinary Infectious Disease Diagnostics (2033)	US$4.9billion

Region-Wise Overview

Country	United States
CAGR (2023 to 2033)	9.8%
CAGR (2017 to 2022)	14%

Country	United Kingdom
CAGR (2023 to 2033)	9.1%
CAGR (2017 to 2022)	13%

Country	Japan
CAGR (2023 to 2033)	9.4%
CAGR (2017 to 2022)	13.6%

Country	South Korea
CAGR (2023 to 2033)	8.5%
CAGR (2017 to 2022)	12.5%

Country	Australia
CAGR (2023 to 2033)	8.1%
CAGR (2017 to 2022)	11.4%

Attributes	Details
US Market Size (2033)	US$1.7 billion
US Market Absolute Dollar Growth (US$ Million/Billion)	US$ 3 billion

Attributes	Details
United Kingdom Market Size (2033)	US$ 206.2 million
United Kingdom Market Absolute Dollar Growth (US$ Million/Billion)	US$ 120 million

Attributes	Details
Japan Market Size (2033)	US$ 351.6 million
Japan Market Absolute Dollar Growth (US$ Million/Billion)	US$ 208.9 million

Attributes	Details
Australia Market Size (2033)	US$174.1million
Australia Market Absolute Dollar Growth (US$ Million/Billion	US$ 94.1 million